ST. LOUIS, Dec. 3, 2015 /PRNewswire/ -- Express Scripts (Nasdaq: ESRX) announced that on December 2, 2015, the Board of Directors of the Company approved an increase in the authorized number of shares that may be repurchased under the Company's share repurchase program by an additional 60 million shares, or a total authorization of 265 million shares, of the Company's common stock.
About Express Scripts
Express Scripts puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible.
Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
SOURCE Express Scripts